We're developing the first drugs that stop the spread of cancer, instead of attacking both cancer and healthy cells. Find out more at remedyplan.com
Location: United States, District of Columbia, Washington
Employees: 1-10
Total raised: $18M
Founded date: 2011
Investors 1
| Date | Name | Website |
| - | Schooner C... | schoonerca... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.05.2025 | - | $18M | - |
Mentions in press and media 4
| Date | Title | Description |
| 13.05.2025 | Remedy Plan Therapeutics Raises $18M Financing | Remedy Plan Therapeutics, a Gaithersburg, MD-based clinical-stage pharmaceutical company developing new, hyperbolic NAMPT inhibitors, raised $18M in funding. Backers included Schooner Capital, Alexandria Venture Investments, and other exist... |
| 02.01.2020 | New Money: The Top DC-Area Funding Announcements of December | December closed out the year with a strong set of funding rounds and acquisitions for D.C.-area companies. There were impressive showings from organizations focused on clean energy, biotech, cybersecurity and education, among other things. ... |
| 21.09.2018 | Remedy Plan Therapeutics wins Bio+Tech Conference pitch competition | The Maryland Tech Council brought the Bio+Tech Conference to Baltimore on Thursday. For the first time, the event closed out with a pitch competition featuring startups from around the state. Remedy Plan Therapeutics was named the winner, a... |
| - | Remedy Plan Therapeutics | “Remedy Plan is a biotechnology company developing the first drugs that halt tumor growth and disrupt the cancer stem cells that cause metastasis.” |